Chinese Biotech Firm InnoCare Plans Hong Kong IPO

(Bloomberg) -- Beijing InnoCare Pharma Tech Co., which is developing treatments for cancer and autoimmune diseases, is planning a Hong Kong initial public offering, people with knowledge of the mat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.